|Articles|February 1, 2015
- BioPharm International-02-01-2015
- Volume 28
- Issue 2
BioPharm International, February 2015 Issue (PDF)
Click the title above to open the BioPharm International February 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
Finding Opportunities in Brazilalmost 11 years ago
Behind the Scenes with Buffersalmost 11 years ago
Colony Counter Increases Accuracyalmost 11 years ago
Peristaltic Pump Ensures Repeatabilityalmost 11 years ago
Tackling Analytical Method Development for ADCsalmost 11 years ago
Cures Require Compromisealmost 11 years ago
Mitigating Risk for Single-Use Assemblies in Sterile Fillingalmost 11 years ago
FDA Sets Policies to Enhance Drug Security and Safetyalmost 11 years ago
Gauging the CMO Biosimilar Opportunityalmost 11 years ago
The Bullish Outlook for BiosimilarsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
